0.4% Lidocaine Hydrochloride and 5% Dextrose Injection Shortage Reported
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage has been reported for 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection, according to the Drug Shortages Canada database.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 6, 2026 and geographically references Canada. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, canada, medication, Lidocaine-Hydrochloride.
What's in Shortage
Drug Name: 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection
Dosage Form: Injection
Current Status: Active
Which Manufacturers Are Affected
The official report (Shortage ID: 179915) does not currently list a specific manufacturer, brand name, or Drug Identification Number (DIN) associated with this shortage entry. Availability status for specific suppliers is not provided in the source data.
Why There's a Shortage
No specific reason for this shortage was provided in the official report.
What Patients Should Do
If you or a family member rely on this medication, please take the following steps:
- Consult your healthcare provider: Discuss your treatment plan and any concerns regarding medication availability.
- Speak with your pharmacist: They can provide the most current information on local stock levels and potential next steps.
- Seek professional guidance: Do not attempt to use alternative medications or change your treatment without consulting a medical professional.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider regarding their specific medical needs and treatment options.
Source
Attribution: Drug Shortages Canada (Shortage ID: 179915).
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,361 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.